Mentari Therapeutics, Inc. (MTRI NASDAQ) stock market data APIs
$18.3471
-2.47(-13.5%)
as of November 12, 2026
Try our APIs with
free plan!
Mentari Therapeutics, Inc. Financial Data Overview
Price chart is built with
Anychart
Mentari Therapeutics, Inc., a biotechnology company, develops and provides therapies for migraine prevention. The company's products include MT-001, an anti-PACAP monoclonal antibody designed for convenient subcutaneous dosing; MT-002, an anti-CGRP; and anti-PACAP bispecific antibody designed to inhibit these complementary pathways. The company was incorporated in 2025 and is based in Sacramento, California.
Prev. Close
18.3471
Open
15.8748
High
19.3372
Low
14.6885
52 wk Range
5.75-23.3
Market Cap
910 M
Shares Outstanding
58 300 K
EPS
-4.2615
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mentari Therapeutics, Inc. data using free add-ons & libraries
Get Mentari Therapeutics, Inc. Fundamental Data
Mentari Therapeutics, Inc. Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
Get Mentari Therapeutics, Inc. Earnings data
Corporate Events Calendar & News package for
$
19.99
/mo.
What’s included:
- Latest Release: 2026-11-06
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mentari Therapeutics, Inc. News
New
Mentari Therapeutics (MTRI) Shares Just Jumped, So What Is Driving Attention Now?
Mentari Therapeutics (MTRI) is in focus after a 1-for-10 stock split that took effect on 5 November 2026, paired with fresh index inclusion and new board-level financial oversight. Recent trading has...
Mentari Therapeutics Announces Closing of Merger with InMed Pharmaceuticals and Previously Announced $490 Million Financing
Mentari Therapeutics, Inc. Mentari is advancing a robust pipeline of biologics for the prevention of migraine, including MT-001 and MT-002, which target clinically validated pathways and have potenti...
Get Mentari Therapeutics, Inc. fresh news feed via Financial News API
Corporate Events Calendar & News package for
$19.99/mo.
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
Best Offer
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.